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ABSTRACT 
The main aim of this paper was to estimate the prevalence of the 
“bad sleepers”, correlate the “sleep quality” with the quality of life, 
and to study the risk factors for “sleep quality” in 98 unselected adult 
patients with epilepsy in a cross-sectional study performed in a pub-
lic teaching hospital. They answered/were evaluated: clinical-socio 
demographics questions, Pittsburg Sleep Quality Index, Depression 
and Anxiety Beck Inventories, and SF-36 Health Survey. They were 
found a high rate of “bad sleepers”; statistically significant difference 
between “sleep quality” in relation to age, depression and anxiety 
symptoms, and three SF-36 concepts (physical role, vitality, and 
mental health). After multiple linear regression analysis, it was found 
that vitality and anxiety, besides mental health, were the predictors 
of lower quality of life in ‘’bad sleepers‘’. However, there was not 
any statistically significant difference regarding seizure frequency, 
nor number of antiepileptic drugs. Consequently, risk factors for low 
“sleep quality” have to be managed. 
Keywords: Epilepsy, anxiety, depression, sleep disorder, quality of 
life.
RESUMO
O principal objetivo deste trabalho foi estimar a prevalência dos 
“maus dormidores”, correlacionar a “qualidade do sono” com a 
qualidade de vida e estudar os fatores de risco para “qualidade do 
sono” em 98 pacientes adultos não selecionados com epilepsia em 
um estudo transversal realizado em um hospital público de ensino. 
Eles responderam/foram avaliados: questões clínicas e sociodemo-
gráficas, Índice de Pittsburg de Qualidade de Sono, Inventários de 
Beck de depressão e ansiedade e Questionário de Qualidade de Vida 
SF-36. Foram encontradas alta taxa de “maus dormidores”; diferen-
ça estatisticamente significativa entre “qualidade do sono” e idade, 
sintomas de depressão e ansiedade, além de três conceitos do SF-36 
(papel físico, vitalidade e saúde mental). Após análise por regressão 
linear múltipla, encontrou-se que a vitalidade e a ansiedade, além 
da saúde mental, foram preditores de baixa qualidade de vida nos 
“maus dormidores”. No entanto, não houve qualquer diferença esta-
tisticamente significativa em relação à frequência de crises, nem nú-
mero de drogas antiepilépticas. Consequentemente, fatores de risco 
para baixa “qualidade do sono” têm de ser controlados.
Palavras-chave: Epilepsia, ansiedade, depressão, transtornos do 
sono, qualidade de vida.
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INTRODUCTION
Sleep is a vital element throughout the life of all 
mammals, and its quality must be preserved. How-
ever, “sleep quality” (SQ) represents a complex phe-
nomenon difficult to define and measure objective-
ly.1 It includes quantitative aspects of sleep, such as 
its duration, latency or number of arousals, as well 
as more purely subjective aspects, such as “depth” 
or “restfulness” of sleep according to Buysse et al.1 
Subjective measurement tools can be used in clini-
cal practice for diagnostic purposes, for monitoring 
treatment responses, in epidemiologic studies and in 
clinical research.2 Some of them are designed for the 
assessment of specific sleep disorders, such as sleepi-
ness or presence of awakenings, while others evalu-
ate sleep in a broad spectrum, especially with regard 
to SQ.2 There is a well know reciprocal relationship 
between sleep and epilepsy, besides the notion that 
sleep disturbances are common among patients with 
epilepsy and, on the other hand, sleep disorders 
can contribute to lack of seizure control.3 Among 
these disorders, both excessive daytime sleepiness 
and obstructive sleep apnea are more frequent in 
patients with epilepsy than the general population. 
Some authors published papers about the relation-
ship between SQ, measured by questionnaire and/or 
polysomnography, and epilepsy,4-9 and some others 
have studied the links between SQ/sleep disorders, 
epilepsy and “quality of life” (QoL).10-19 There are 
also many studies dealing with the general question 
“sleep quality” and epilepsy, but the literature re-
mains meager and ambiguous regarding the preva-
lence of “bad sleepers” evaluated by means of a for-
mal test with this aim (such as Sleep Quality Index 
Pittsburgh-PSQI), and the correlation between SQ 
and QoL, besides the study of several risk factors for 
the SQ [altogether] in patients with epilepsy: the 
aims of this study. 
METHODS
This is a cross-sectional study based on 100 unselect-
ed patients data from the outpatient clinic of the 
Neurological Institute, Universidade Federal do Rio 
de Janeiro, Brazil, over a 1 year period. The patients 
were men and woman aged between 18 and 60 who 
had been diagnosed with epilepsy (focal or general-
ized) according to International League against Epi-
lepsy criteria. The patients agreed with the informed 
consent, and the study was approved by the local ethics 
committee (The Sleep disorders in adult patients with 
epilepsy: study of prevalence, quality of sleep and life 
based on questionnaire). The patients were able to 
complete a self-administered questionnaire. Two 
subjects were excluded because of missing data on 
Sleep Quality Index Pittsburgh-PSQI. Only patients 
on stable antiepileptic drugs regimen were included 
(no changes over the last four weeks). Patients with 
other active neurological diseases were excluded.
The auto-applied questionnaires were answered 
before the medical consultation and they included: 
(1) clinical and socio-demographic questions (age, 
gender, education – in years, seizure frequency, and 
number of epileptic drugs); (2) SQ (dependent vari-
able) evaluated by means of the PSQI.1 This ques-
tionnaire comprise 19 questions that are combined 
to form seven components (sleep quality-individual 
perceptions about the quality of sleep; sleep latency – 
time required to start sleep; sleep duration-duration 
of sleep or how long it they stay asleep; habitual sleep 
efficiency – the relationship between the number of 
hours slept and the number of hours remaining in 
bed, not necessarily asleep; sleep disturbance – pres-
ence of situations that compromise the hours of 
sleep; use of sleeping medication – analyses the use of 
sleeping medication; daytime dysfunction – describes 
the disturbances and daytime sleepiness during the 
day referring to changes in the disposition for the 
performance of routine activities), each varying from 
0 to 3. The seven components combine to form a 
global score that varies from 0 to 21, where 0 indi-
cates no difficulty and 21 indicates severe difficulty. 
Global score ≥ 5 distinguishes “bad” from “good” 
sleepers 1; (3) depression symptoms were evaluated 
by the Beck Depression Inventory.20,21 Depression 
was defined by a score of ≥ 12;19-21 (4) anxiety symp-
toms were examined by the Beck Anxiety Invento-
ry.19 Anxiety was defined by a score of ≥ 10; 5) QoL 
was evaluated by the Short Form [36] Health Survey 
SF-36.20 The SF-36 is an instrument comprising 36 
items that assess two health components: the physi-
cal and mental. The first has the following concepts: 
1 – physical functioning (performance of daily ac-
tivities, such as ability to care, dressing, bathing and 
climbing stairs); 2 – physical role (physical health im-
pact on the performance of daily activities and/or 
professional); 3 – pain (pain level and the impact on 
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performance of daily activities and/ or professional); 
4 – general health (subjective perception of gener-
al health). The second component (mental health) 
consists of the dimensions: 5 – vitality (subjective 
perception of health status), 6 – social functioning 
([reflecting the condition of physical health on so-
cial activities), 7 – emotional role (emotional reflec-
tion of the conditions in the performance of daily 
activities and/or professional), and 8 – mental health 
(scale of mood and well-being). The results of each 
component range from 0 to 100 (from worst to best 
health status) – greater punctuation, better QoL.22,23 
We studied the prevalence of “bad sleepers”, and 
its 95% confidence interval (CI). Descriptive and infer-
ential statistics were used by means of non-parametric 
tests according to the variable type, such as Spear-
man’s rank correlation coefficient, chi-square test of 
independence, and Mann-Whitney U test by using 
the statistical package SPSS 11.01. The option was 
for the two tailed tests, and the significance of 0.05. 
The multivariate analysis was performed by multiple 
linear regression to assess the influence of the indica-
tors of accessibility on SQ (evaluated by PSQI). The 
process of selection of variables was stepwise forward, 
at level of 5%, which selects the smallest subgroup of 
independent variables that influence the SQ. 
For comparison purposes, our data regarding 
sleep quality measured by PSQI was compared with 
that of hypertrophic cardiomyopathy and control 
hospital based24 besides that of insomnia and depres-
sion2 Brazilian patients.
RESULTS
The main characteristics of the studied population 
are presented on table 1. The mean ± SD age of the 
sample was 39.71 ± 12.24. More than half of the 
participants were men. Most patients had generali-
zed seizures, experienced fewer than four seizures 
during the past year, and 51% used two or more 
antiepileptic drugs during this period. The mean ± 
SD PSQI global score was 6.62 ± 4.3. Sixty-six partici-
pants (67.3%) were poor sleepers (global PSQI ≥ 5). 
The table 2 gives the coefficient x² providing the 
relationship between clinical and socio-demographic 
variables. We found statistically significant difference 
between bad or good sleepers in relation to age, de-
pression, anxiety when these variables were dichoto-
mized. The table 3 gives the correlation between QS 
and QoL variables. We observed that there was cor-
relation between three domains of the SF-36 (physi-
cal role, vitality, and mental health), depression and 
anxiety with QS (Table 3). 
Table 1. Patient characteristics
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PSQI: Pittsburgh Sleep Quality Index. 
Table 2. Relationship between socio-demographic and clinical variables 
in relation to the quality of sleep (bad and good sleepers)
Variable Category Sleepers< 5 Sleepers ≥ 5 p*
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Multivariate analyses by means of multiple linear 
regressions were conducted to examine the associa-
tions between SQ and epilepsy-related QoL (Tables 
4 and 5). We found that vitality (including in SF-
36-5), mental health (including in SF-36-8, and 
anxiety – measured by Beck Anxiety Inventory) were 
independently predictive of lower SQ (Table 4). On 
a second step, the vitality variable was excluded to 
identify other significant predictors of SQ in multi-
variate analysis: mental health (Table 5).
DISCUSSION
Our studied population demonstrated a high preva-
lence of low SQ (PSQI 6.62 ± 4.3), but not in the 
grade demonstrated by Bertolazi et al.2 for insomnia 
and depression patients. Bertolazi et al.,2 described 
in their study that the mean score for: control sub-
jects [participants with history of normal sleep hab-
its, without notice snoring] was 2.5 ± 2; for patients 
with OSA, 8.1 ± 4.0; for insomnia patients, 12.8 ± 
3.7; for those with depression, 14.5 ± 3.7. The study 
on patients with hypertrophic cardiomyopathy in the 
same geographic region applied PSQI global score 
shown PSQI > 4: control (without a previous diag-
nosis of hypertrophic cardiomyopathy) – 48% (0.34-
0.61); patients – 76% (0.67-0.83) vs 67.3% (0.58-
0.76) in the studied epileptic patients.24
We found that vitality, anxiety, and mental health 
[concepts of the SF-36] independently are all related 
to QS: mental health components more important 
than physical health components [physical role] that 
was also impaired. Neves and Gomes19 studied the 
same patients regarding low vitality and its important 
relationship to low SQ measured by PSQI. Kwan et 
al.16 point out the effect of anxiety and depression 
on QoL scores. 
In relation to others diseases applying similar ap-
proach, Taylor-Gjevre et al.25 studied SQ in patients 
with rheumatoid arthritis and osteoarthritis using 
PSQI, SF-36, as we use, besides polysomnography. 
They identified global functioning to be an inde-
pendent predictor for higher global PSQI scores in 
rheumatoid arthritis patients, whereas in osteoarthri-
tis patients predictors were SF-36 mental component 
summary (regarding the mentioned instruments used 
before), the last more similar to ours patients. In the 
studied sample, it was not t demonstrated any impor-
tant relationship between SQ and education, gender, 
seizure type, frequency of seizures, or number of an-
tiepileptic drugs in use. It was not found correlation 
frequency of seizures and number of antiepileptic 
drugs because the majority of patients were pharma-
cologically controlled. In the other hand, it was found 
relationship with age, but only when this variable was 
dichotomized (cut off point, 40 years old).
The study findings call attention to importance of 
the low SQ as a whole, besides the under-diagnosed 
psychiatric symptoms in these patients. The psycho-
social aspects of patient care and the SQ should be 
Table 3. Correlation between quality of sleep with clinical and quality of 
life variables 
Variables Sleep quality index Pittsburgh
rs p value
Age 0.060 0.55
Seizure frequency/year 0.077 0.45
Number of antiepileptic drugs 0.104 0.31
Depression 0.518 < 0.0001
Anxiety 0.588 < 0.0001
SF-36
1 – Physical functioning -0.314 0.002
2 – Physical role -0.506 < 0.0001
3 – Pain -0.344 0.001
4 – General health -0.478 < 0.0001
5 – Vitality -0.635 < 0.0001
6 – Social functioning -0.463 < 0.0001
7 – Emotional role -0.466 < 0.0001
8 – Mental health -0.623 < 0.0001
Table 4. Multiple linear regression (step 1) 
Variable Coefficient SE* P value R²
SF-36-vitality -0.0732 0.016 < 0.0001 0.408
Anxiety 0.1150 0.036 0.002
Dependent Variable: Sleep quality Index Pittsburgh.
* SE: standard error.
Table 5. Multiple linear regression (step 2)




-0.0660 0.002 < 0.0001 0.412
Anxiety 0.127 0.004 0.001
Dependent variable: Sleep quality Index Pittsburgh.
R²: squared multiple correlation coefficient.
SF-36-vitality was not considered at this stage.
* SE: standard error.
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an important focus on seizure management, but are 
relatively neglected in everyday clinical practice.
This is an investigation of the impact of QoL 
on the QS in patients with epilepsy. Others studies 
only mentioned the impact of sleep disturbances on 
QoL,13,15-17 and several authors described the QoL in 
patients of epilepsy.21 Carrion et al.,8 evaluated the 
SQ in patients with refractory seizures who under-
gone epilepsy surgery. 
We propose in a further study correlate these 
subjective changes with the structure of the sleep 
by polysomnography, trying to find interactions 
between nocturnal seizures, sleep stages, interictal 
epileptiform activity, exacerbation of seizures by dis-
rupted sleep, the effects of number of antiepileptic 
drugs on sleep architecture, and daytime vigilance. 
Two papers did such type of study by Cho et al.,9 and 
Bell et al.4 The first compared the effect of levetirace-
tam monotherapy with the effect of carbamazepine-
CR on subjective SQ and objective sleep parameters 
in patients with focal epilepsy. Bell et al. evaluated 
the objective and subjective effect of the use of leve-
tiracetam plus carbamazepine therapy on SQ of pa-
tients with focal epilepsy and healthy subjects with 
the use of levetiracetam only.
CONCLUSION
Our findings suggest that poor sleep is frequent 
among patients with epilepsy, and is linked with 
anxiety, loss of vitality (the fifth component of SF-
36), and mental health (the eighth conception of 
SF36) independently. These results emphasize the 
importance of screening the SQ and psychiatric co-
morbidities in patients with epilepsy. Therapeutic 
interventions including psychiatric and sleep assess-
ment appear to be crucial for preserving QoL, and 
efforts must be made to evaluate how the modifica-
tion of the variables could improve the QoL and sei-
zure control in patients with epilepsy. We could also 
set targets to improve control of the SQ and conse-
quently the QoL, indicating a major breakthrough in 
the treatment of the patients with epilepsy.
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